The size of molecules able to 
INTRODUCTION
In a recent study, Wallace, Beastall, Cook et al. (1986) successfully used microencapsulated antibody for an extremely robust, large-scale screening assay for the measurement of 17-hydroxyprogesterone in babies. The technical simplicity of the procedure was of great advantage and allowed a large number (120 000) of samples to be screened. Antibodies are physically retained within the microcapsules because they are too large to escape through the pores in the semipermeable membrane. Antibody-containing microcapsules, when used for radioimmunoassay (RIA), are light enough to remain suspended during the incubation stage yet are easily sedimented by centri¬ fugation for separation of the antibody-bound fraction. The technique is useful for the measurement of compounds small enough to penetrate the membrane pores and interact with the entrapped antibody.
The potential of microencapsulated antibody in immunoassay was first recognized and explored by Halpern & Bordens (1979a) , who reported a method using microcapsules for the measurement of digoxin. Assays soon followed for free thyroxine (Ashkar, Buehler, Chan & Hourani, 1979; Halpern & Bordens, 19796) , cortisol (Bordens & Halpern, 1980) and testo¬ sterone (Chan, Provost, Stella & Buehler, 1980 (Wallace & Wood, 1984) and reagents prepared in this way have been used for the measurement of both steroid and thyroid hormones Wallaces al. 1986 ).
To date, radioimmunoassays using microencapsu¬ lated antibodies have been applied only to the measurement of antigens with a molecular weight below 800. The current study was undertaken to gain information on the size limits of molecules that can enter the capsule through the ultrathin nylon mem¬ brane and bind to the antibody. Establishment of the upper limit of molecular size for which this technique can be used will facilitate further development of simi¬ lar RIA systems. A preliminary report of some of these results has been given previously (Duffy, Logue & Wallace, 1986) .
MATERIALS AND METHODS
All the reagents required for the preparation of the microcapsules have been detailed previously (Wallace & Wood, 1984 (Wallace & Wood, 1984 (Cook & Beastall, 1987) and protein (Edwards, Lalloz & Pull, 1983) (Wallace & Wood, 1984) , so there is likely to be a range of pore sizes within batch. The range in size of microcapsules is the same within and between batches and it is prob¬ able that the pore size behaves similarly. We obtained no evidence for the binding of hormones varying between different preparations of microcapsules. Of all the hormones tested, insulin (molecular weight 6000) appeared to be closest to the pore size. As a result of X-ray crystallography, much is known about the molecular structure of insulin. It is probable that this hormone, a globular protein, is present in sol¬ ution in its larger form as a hexamer, which produces an ellipsoid 5-0 nm in diameter and 3-5 nm in length, but smaller dimers and monomers might also be present (Blundell, Dobson, Dobson et al. 1971 ).
This information suggests that the maximum pore diameter in the microcapsule membrane is below 3-5 nm since some insulin was able to bind with its microencapsulated antibody, but not to the extent achieved when the antibody was released from the microcapsules by sonication.
Parathyroid hormone, the next largest hormone examined, molecular weight 10 000, was unable to enter the microcapsules, although the 1-34 amino acid fragment of PTH entered freely. The exact threedimensional shape of these molecules has not been determined by crystallographic analysis, but struc¬ tural information has been inferred from hydrodynamic and dark-field electron microscopic studies (Cohn & Elting, 1983 ). It appears that PTH has two domains connected by a fairly rigid stalk, it migrates electrophoretically as an asymmetric rather than globular protein and has a Stokes radius of 20nm although, from dark-field electron microscopy, the (Fiskin et al. 1977) . Therefore, it is likely that the upper limit of the pore size is greater than 1 -8 nm.
Our findings are in general agreement with those of Chang (1972) . He calculated the pore diameter of semipermeable nylon microcapsules to be approxi¬ mately 1-8 nm by examining the permeability charac¬ teristics of various test solutions in the microcapsules. In hypertonic solutions, microcapsules collapse (crenate), but as equilibrium is reached between the internal hydrostatic pressure and the external osmotic pressure, the capsules regain their shape (Chang, 1964) . Using a number of solutions, i.e. sucrose, dextrose, ethylene glycol and propylene glycol, at dif¬ ferent concentrations, Chang (1964) 
